In this case the company would not be able to recover the annual membership fee but still has the option of contacting A.I.S.E. regarding possible in vitro testing of the formulation to be classified, and subsequent addition of the test data to the DetNet database. 
It has to be noted that in this case A.I.S.E. funds the testing, the company would retain ownership of the formulation (formally releasing it as a Reference Formulation in the database) but A.I.S.E. would own the test data - the company would not be eligible for data compensation in this instance.  If the company subsequently uses the data for classification purposes, they would not pay Classification Logging Fees.